Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Total Current Liabilities: 2012-2024

Historic Total Current Liabilities for CorMedix (CRMD) over the last 10 years, with Dec 2024 value amounting to $33.8 million.

  • CorMedix's Total Current Liabilities rose 623.14% to $133.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.6 million, marking a year-over-year increase of 623.14%. This contributed to the annual value of $33.8 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, CorMedix's Total Current Liabilities is $33.8 million, which was up 436.21% from $6.3 million recorded in FY2022.
  • In the past 5 years, CorMedix's Total Current Liabilities ranged from a high of $33.8 million in FY2024 and a low of $4.2 million during FY2020.
  • Moreover, its 2-year median value for Total Current Liabilities was $20.1 million (2022), whereas its average is $20.1 million.
  • Per our database at Business Quant, CorMedix's Total Current Liabilities dropped by 28.58% in 2020 and then grew by 28.44% in 2021.
  • Yearly analysis of 4 years shows CorMedix's Total Current Liabilities stood at $4.2 million in 2020, then rose by 28.44% to $5.3 million in 2021, then rose by 18.07% to $6.3 million in 2022, then reached $33.8 million in 2024.